Physician profile
Sakeena Payne
NPI 1598023962
$1,431.86
in general payments reported to CMS, 2019-2025
12 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $116 · 2023: $545 · 2024: $302 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $309.00 | 2022-2025 | |
| Acclarent, INC | $274.27 | 2023 | Trudi Nav Cable |
| Integra Lifesciences Corporation | $267.51 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Optinose US, INC. | $131.91 | 2022-2024 | |
| Neurent Medical Limited | $119.42 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Pfizer INC. | $116.86 | 2023 | |
| Aerin Medical INC. | $62.94 | 2024-2025 | |
| Inspire Medical Systems, INC. | $46.95 | 2023-2025 | Inspire |
| Medtronic, INC. | $37.24 | 2024 | Propel |
| Hikma Pharmaceuticals USA | $35.50 | 2024-2025 | Ryaltris |
| Stryker Corporation | $15.19 | 2024 | Xpress Loprofile |
| Phadia US INC. | $15.07 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sakeena Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.